High Court To Hear Patent Case Over On-Sale Bar
The U.S. Supreme Court on Monday agreed to review a Federal Circuit decision that invalidated a Helsinn Healthcare SA nausea drug patent and to interpret changes made in the America Invents...To view the full article, register now.
Already a subscriber? Click here to view full article